Intracardiac emboli as first presentation of cardiac AL amyloidosis.

Daubert JP, Eldar M, Gold MR, Goldberger JJ, Goldenberg I, Lichstein E, Pitschner H, Rashtian M, Solomon S, Viskin S, Wang P, Moss AJ. Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 2011;123:1061–1072. 14. Fang F, Chan JY, Yip GW, Xie JM, Zhang Q, Fung JW, Lam YY, Yu CM. Prevalence and determinants of left ventricular systolic dyssynchrony in patients with normal ejection fraction received right ventricular apical pacing: a real-time threedimensional echocardiographic study. Eur J Echocardiogr 2010;11:109–118. 15. Yu CM, Chan JY, Zhang Q, Omar R, Yip GW, Hussin A, Fang F, Lam KH, Chan HC, Fung JW. Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med 2009;361:2123–2134. 16. Chan JY, Fang F, Zhang Q, Fung JW, Razali O, Azlan H, Lam KH, Chan HC, Yu CM. Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial. Eur Heart J 2011;32:2533–2540. 17. Yu CM, Chan JYS, Fang F, Zhang Q, Razali O, Yip GWK, Azlan H, Chan HCK, Fung JWH. http://www.escardio.org/congresses/esc-2010/congress-reports/ Pages/711-1-PACE.aspx. (20 January 2012). 18. Auger D, Bleeker GB, Bertini M, Ewe SH, van Bommel RJ, Witkowski TG, Ng ACT, van Erven L, Schalij MJ, Bax JJ, Delgado V. Effect of cardiac resynchronization therapy in patients without left intraventricular dyssynchrony. Eur Heart J 2012;33:913–920. 19. Stavrakis S, Lazzara R, Thadani U. The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis. J Cardiovasc Electrophysiol 2011;in press. 20. Sipahi I, Carrigan TP, Rowland DY, Stambler BS, Fang JC. Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Arch Intern Med 2011;171:1454–1462.